Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
135
datasets available to search
ShareScore release 0.9.0
Dataset results
135 results for “acromegaly”
Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues
ClinicalTrials.gov study NCT02354508. IPD Sharing: YES. Countries: 15. Publications: 1.
Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
ClinicalTrials.gov study NCT02060383. IPD Sharing: YES. Countries: 12. Publications: 2.
Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly
ClinicalTrials.gov study NCT00372697. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Lanreotide Autogel® 60, 90 or 120 mg With Lanreotide 40 mg Prolonged Release (PR) in Acromegaly
ClinicalTrials.gov study NCT02493517. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly
ClinicalTrials.gov study NCT02685709. IPD Sharing: NO. Countries: 13. Publications: 3.
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve)
ClinicalTrials.gov study NCT03792555. IPD Sharing: NO. Countries: 8. Publications: 1.
Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
ClinicalTrials.gov study NCT00600886. IPD Sharing: Not stated. Countries: 27. Publications: 3.
Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly
ClinicalTrials.gov study NCT01412424. IPD Sharing: Not stated. Countries: 13. Publications: 2.
Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly
ClinicalTrials.gov study NCT03252353. IPD Sharing: NO. Countries: 17. Publications: 4.
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
ClinicalTrials.gov study NCT00447499. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly
ClinicalTrials.gov study NCT00171730. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)
ClinicalTrials.gov study NCT02299089. IPD Sharing: NO. Countries: 4. Publications: 1.
Acromegaly Combination Treatment Study
ClinicalTrials.gov study NCT01538966. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
ClinicalTrials.gov study NCT01137682. IPD Sharing: UNDECIDED. Countries: 18. Publications: 2.
An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge)
ClinicalTrials.gov study NCT03789656. IPD Sharing: NO. Countries: 12. Publications: 1.
Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly
ClinicalTrials.gov study NCT02396953. IPD Sharing: Not stated. Countries: 12. Publications: 1.
Real-World Evidence of Effectiveness and Safety of Pasireotide in the Treatment of Acromegaly: A Systematic Review and Meta-Analysis
<p>Dataset for the study: Real-World Evidence of Effectiveness and Safety of Pasireotide in the Treatment of Acromegaly: A Systematic Review and Meta-Analysis </p>
Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
ClinicalTrials.gov study NCT00446082. IPD Sharing: Not stated. Countries: 6. Publications: 1.
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
ClinicalTrials.gov study NCT04076462. IPD Sharing: NO. Countries: 10. Publications: 2.
Cardiac (CMRI) Assessment of Acromegaly
ClinicalTrials.gov study NCT02948322. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.